نتایج جستجو برای: lansoprazole allergy

تعداد نتایج: 53339  

2015
Halil Rakici Remzi Adnan Akdogan Teslime Ayaz Recep Bedir

Aim. We designed this trial to find answers to the following questions. (1) Does the success rate decrease in a country where HP prevalence is high? (2) Can we provide benefit by simultaneously treating the partners of infected patients? Materials and Methods. The first group consisted of 102 HP-positive patients, and both the patients and their HP-positive partners were treated. The second gro...

2016
Murat Kekilli Ibrahim K. Onal Serkan Ocal Zeynal Dogan Alpaslan Tanoglu

BACKGROUND/AIM Increasing resistance of Helicobacter pylori to antimicrobials necessitated the development of new regimens and the modification of existing regimens. The present study aimed to compare the efficacy of two bismuth-containing quadruple regimens-one including clarithromycin (C) instead of metronidazole (M) and triple therapy. PATIENTS AND METHODS Patients with H. pylori infection...

2013
Jai Moo Shin Nayoung Kim

Proton pump inhibitor (PPI) is a prodrug which is activated by acid. Activated PPI binds covalently to the gastric H(+), K(+)-ATPase via disulfide bond. Cys813 is the primary site responsible for the inhibition of acid pump enzyme, where PPIs bind. Omeprazole was the first PPI introduced in market, followed by pantoprazole, lansoprazole and rabeprazole. Though these PPIs share the core structur...

2018
Naomi Uemura Yoshikazu Kinoshita Ken Haruma Takashi Yao Ryoji Kushima Tatsuhiro Kanoo

Erosive esophagitis (EE) occurs when the epithelial mucosa is damaged due to gastric acid reflux, and the incidence of this disease is increasing in Japan due to changes in diet and lifestyle. The condition can be treated using proton pump inhibitors (PPIs) that act by irreversibly blocking the H+,K+-ATPase responsible for acid secretion. Vonoprazan is a K+ competitive channel inhibitor, which ...

Journal: :Antimicrobial agents and chemotherapy 2008
Hidenori Matsui Chihiro Aikawa Yukie Sekiya Shinichi Takahashi Somay Yamagata Murayama Masahiko Nakamura

Triple-agent therapy with lansoprazole (15 mg/kg)-clarithromycin (50 mg/kg)-amoxicillin (50 mg/kg) twice daily for 7 days fully cleared "Candidatus Helicobacter heilmannii" from infected mouse stomachs. Moreover, gastric mucosa-associated lymphoid tissue lymphoma-like lesions in the stomach nearly disappeared in the treated mice 4 months after the therapy.

Journal: :Reumatologia clinica 2009
Emilio Márquez-Contreras Vicente Gil-Guillén Albert Nadal-Sánchez M José Plazas-Fernández Joan Heras-Navarro Jordi Galván-Cervera Joana Porcel-Carbonell

OBJECTIVE To assess compliance with oral lansoprazole disintegrating tablets (LODT) in patients treated by traumatology specialists. MATERIAL AND METHOD A multicenter, observational, cross-sectional study involving 370 traumatology specialists and patients aged 18 or more. Study logistics were sponsored by Almirall Laboratories, S.A.; neither investigators nor patients received any economic c...

2008
S. K. KULKARNI R. S. KADAM

DOM in marketed capsule formulation. The assay values were in good agreement with the corresponding labeled claim. The recovery studies show accuracy of the method. On observing the validation parameters both the methods were found to be accurate, precise and speciÞ c. Hence the methods can be employed for quality control and routine analysis of lansoprazole and domperidone in pharmaceutical fo...

Journal: :Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 1996

2014
Hyun Chul Lim Yong Jae Lee Byoungrak An Seung Woo Lee Yong Chan Lee Byung Soo Moon

BACKGROUND Rifabutin has been known to be effective in multidrug-resistant Helicobacter pylori-harboring patients undergoing treatment failure for H. pylori infection. AIM To evaluate the efficacy of 7-day treatment regimen consisting rifabutin daily but increasing the dose of amoxicillin and lansoprazole in patients who have failed first and second eradication and to assess the side effect p...

2016
Jyh-Ming Liou Chieh-Chang Chen Chi-Yang Chang Mei-Jyh Chen Chien-Chuan Chen Yu-Jen Fang Ji-Yuh Lee Tsung-Hua Yang Jiing-Chyuan Luo Jeng-Yih Wu Tai-Cherng Liou Wen-Hsiung Chang Yao-Chun Hsu Cheng-Hao Tseng Chun-Chao Chang Ming-Jong Bair Tzeng-Ying Liu Chun-Fu Hsieh Feng-Yun Tsao Chia-Tung Shun Jaw-Town Lin Yi-Chia Lee Ming-Shiang Wu

OBJECTIVE Significant heterogeneity was observed in previous trials that assessed the efficacies of sequential therapy for 10 days (S10) versus triple therapy for 14 days (T14) in the first-line treatment of Helicobacter pylori. We aimed to compare the efficacy of S10 and T14 and assess the factors affecting their efficacies. DESIGN We conducted this open-label randomised multicentre trial in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید